Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (247)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,133
Price
$536.02
Total Value
$607.31K
Shares Held After
47,653
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
995
Price
$534.94
Total Value
$532.27K
Shares Held After
48,786
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
232
Price
$534.09
Total Value
$123.91K
Shares Held After
49,781
% of Holdings
0.5%
4D Molecular Therapeutics, Inc. (FDMT)
Kirn David — Director
Shares
114,746
Price
$10.47
Total Value
$1.20M
Shares Held After
942,485
% of Holdings
10.9%
ZEVRA THERAPEUTICS, INC. (ZVRA)
Thompson Rahsaan — Chief Legal & Compliance
Shares
34,557
Price
$12.68
Total Value
$438.30K
Shares Held After
80,235
% of Holdings
30.1%
Spyre Therapeutics, Inc. (SYRE)
HENDERSON MICHAEL THOMAS — Director
Shares
20,000
Price
$100.00
Total Value
$2.00M
Shares Held After
68,606
% of Holdings
22.6%
CRESCENT BIOPHARMA, INC. (CBIO)
Scalzo Richard William — Chief Financial Officer
Shares
1,112
Price
$17.99
Total Value
$20.00K
Shares Held After
20,298
% of Holdings
5.2%
CRESCENT BIOPHARMA, INC. (CBIO)
Bispham Barbara Harlin — General Counsel and Corporate Secretary.
Shares
1,218
Price
$17.99
Total Value
$21.91K
Shares Held After
19,330
% of Holdings
5.9%
CRESCENT BIOPHARMA, INC. (CBIO)
McNeill Jonathan — President and COO
Shares
20,549
Price
$17.99
Total Value
$369.68K
Shares Held After
139,158
% of Holdings
12.9%
CRESCENT BIOPHARMA, INC. (CBIO)
Pinkas Jan — Chief Scientific Officer
Shares
1,288
Price
$17.99
Total Value
$23.17K
Shares Held After
22,239
% of Holdings
5.5%
CRESCENT BIOPHARMA, INC. (CBIO)
Im Ellie Eunkyung — Chief Medical Officer
Shares
1,219
Price
$17.99
Total Value
$21.93K
Shares Held After
22,069
% of Holdings
5.2%
CRESCENT BIOPHARMA, INC. (CBIO)
Lynch Ryan — Treasurer, Senior Vice President of Finance and Chief Accounting Officer.
Shares
465
Price
$17.99
Total Value
$8.37K
Shares Held After
13,871
% of Holdings
3.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,250
Price
$541.25
Total Value
$676.56K
Shares Held After
18,876
% of Holdings
6.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
280
Price
$539.83
Total Value
$151.15K
Shares Held After
20,126
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,994
Price
$539.13
Total Value
$1.08M
Shares Held After
20,406
% of Holdings
8.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,266
Price
$538.23
Total Value
$1.22M
Shares Held After
22,400
% of Holdings
9.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
840
Price
$537.18
Total Value
$451.23K
Shares Held After
24,666
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,091
Price
$536.05
Total Value
$584.83K
Shares Held After
25,506
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
865
Price
$534.98
Total Value
$462.76K
Shares Held After
26,597
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
164
Price
$534.06
Total Value
$87.59K
Shares Held After
27,462
% of Holdings
0.6%
CG Oncology, Inc. (CGON)
POST LEONARD E — Director
Shares
5,000
Price
$65.00
Total Value
$325.00K
Shares Held After
0
% of Holdings
100.0%
CRESCENT BIOPHARMA, INC. (CBIO)
Brumm Joshua T — Director
Shares
42,305
Price
$17.99
Total Value
$761.07K
Shares Held After
281,212
% of Holdings
13.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,253
Price
$102.48
Total Value
$128.41K
Shares Held After
617,663
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
918
Price
$101.61
Total Value
$93.28K
Shares Held After
618,916
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
7,879
Price
$100.17
Total Value
$789.24K
Shares Held After
619,834
% of Holdings
1.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
7,319
Price
$99.57
Total Value
$728.75K
Shares Held After
627,713
% of Holdings
1.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
3,603
Price
$98.58
Total Value
$355.18K
Shares Held After
635,032
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,247
Price
$97.68
Total Value
$219.49K
Shares Held After
638,635
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,919
Price
$96.24
Total Value
$280.92K
Shares Held After
640,882
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,648
Price
$95.12
Total Value
$156.76K
Shares Held After
643,801
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
286
Price
$94.48
Total Value
$27.02K
Shares Held After
645,449
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,179
Price
$92.14
Total Value
$200.77K
Shares Held After
645,735
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
8,990
Price
$102.48
Total Value
$921.30K
Shares Held After
3,490,653
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
6,597
Price
$101.61
Total Value
$670.32K
Shares Held After
3,499,643
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
56,348
Price
$100.17
Total Value
$5.64M
Shares Held After
3,506,240
% of Holdings
1.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
52,442
Price
$99.57
Total Value
$5.22M
Shares Held After
3,562,588
% of Holdings
1.5%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
25,976
Price
$98.58
Total Value
$2.56M
Shares Held After
3,615,030
% of Holdings
0.7%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
16,084
Price
$97.68
Total Value
$1.57M
Shares Held After
3,641,006
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
20,903
Price
$96.24
Total Value
$2.01M
Shares Held After
3,657,090
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
11,783
Price
$95.12
Total Value
$1.12M
Shares Held After
3,677,993
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,035
Price
$94.48
Total Value
$192.27K
Shares Held After
3,689,776
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
14,921
Price
$92.14
Total Value
$1.37M
Shares Held After
3,691,811
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,341
Price
$104.38
Total Value
$139.97K
Shares Held After
613,762
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,560
Price
$103.42
Total Value
$264.76K
Shares Held After
615,103
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
9,584
Price
$104.38
Total Value
$1.00M
Shares Held After
3,462,756
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
18,313
Price
$103.42
Total Value
$1.89M
Shares Held After
3,472,340
% of Holdings
0.5%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
699
Price
$82.14
Total Value
$57.42K
Shares Held After
15,312
% of Holdings
4.4%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
888
Price
$80.01
Total Value
$71.05K
Shares Held After
16,011
% of Holdings
5.3%
Kymera Therapeutics, Inc. (KYMR)
Goodman Noah — Chief Business Officer
Shares
2,500
Price
$99.00
Total Value
$247.50K
Shares Held After
50,195
% of Holdings
4.7%
Oncotelic Therapeutics, Inc. (OTLC)
Shah Amit B. — CFO
Shares
20,000
Price
$0.05
Total Value
$1.00K
Shares Held After
378,837
% of Holdings
5.3%
Showing 1–50 of 247 transactions (page 1 of 5)